Class I HDAC imaging using [³H]CI-994 autoradiography

References

• Clayton AL, Hazzalin CA, Mahadevan LC. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 2006; 23:289 - 96; http://dx.doi.org/10.1016/j.molcel.2006.06.017; PMID: 16885019
   PubMed Web of Science ®Google Scholar
• Cohen I, Poręba E, Kamieniarz K, Schneider R. Histone modifiers in cancer: friends or foes?. Genes Cancer 2011; 2:631 - 47; http://dx.doi.org/10.1177/1947601911417176; PMID: 21941619
   PubMedGoogle Scholar
• Spencer CA, Kruhlak MJ, Jenkins HL, Sun X, Bazett-Jones DP. Mitotic transcription repression in vivo in the absence of nucleosomal chromatin condensation. J Cell Biol 2000; 150:13 - 26; http://dx.doi.org/10.1083/jcb.150.1.13; PMID: 10893252
   PubMed Web of Science ®Google Scholar
• Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009; 10:32 - 42; http://dx.doi.org/10.1038/nrg2485; PMID: 19065135
   PubMed Web of Science ®Google Scholar
• Hendricks JA, Keliher EJ, Marinelli B, Reiner T, Weissleder R, Mazitschek R. In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA). J Med Chem 2011; 54:5576 - 82; http://dx.doi.org/10.1021/jm200620f; PMID: 21721525
   PubMed Web of Science ®Google Scholar
• Wilting RH, Dannenberg JH. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist Updat 2012; 15:21 - 38; http://dx.doi.org/10.1016/j.drup.2012.01.008; PMID: 22356866
   PubMed Web of Science ®Google Scholar
• Chavan AV, Somani RR. HDAC inhibitors - new generation of target specific treatment. Mini Rev Med Chem 2010; 10:1263 - 76; http://dx.doi.org/10.2174/13895575110091263; PMID: 20701588
   PubMed Web of Science ®Google Scholar
• Shein NA, Shohami E. Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med 2011; 17:448 - 56; http://dx.doi.org/10.2119/molmed.2011.00038; PMID: 21274503
   PubMed Web of Science ®Google Scholar
• Jia H, Kast RJ, Steffan JS, Thomas EA. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington’s disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum Mol Genet 2012; 21:5280 - 93; http://dx.doi.org/10.1093/hmg/dds379; PMID: 22965876
   PubMed Web of Science ®Google Scholar
• Schmalbach S, Petri S. Histone deacetylation and motor neuron degeneration. CNS Neurol Disord Drug Targets 2010; 9:279 - 84; http://dx.doi.org/10.2174/187152710791292684; PMID: 20406183
   PubMed Web of Science ®Google Scholar
• Echaniz-Laguna A, Bousiges O, Loeffler JP, Boutillier AL. Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases. Curr Med Chem 2008; 15:1263 - 73; http://dx.doi.org/10.2174/092986708784534974; PMID: 18537606
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Rodriguez-Menendez V, Sala G, Di Francesco JC, Ferrarese C. Valproate and HDAC inhibition: a new epigenetic strategy to mitigate phenotypic severity in ALS?. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6:185 - 6; http://dx.doi.org/10.1080/14660820510033614; PMID: 16183561
   PubMed Web of Science ®Google Scholar
• Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?. Mol Pharmacol 2010; 77:126 - 35; http://dx.doi.org/10.1124/mol.109.061333; PMID: 19917878
   PubMed Web of Science ®Google Scholar
• Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008; 7:854 - 68; http://dx.doi.org/10.1038/nrd2681; PMID: 18827828
   PubMed Web of Science ®Google Scholar
• Fass DM, Schroeder FA, Perlis RH, Haggarty SJ. Epigenetic mechanisms in mood disorders: Targeting neuroplasticity. Neuroscience 2013; •••:S0306 - 4522; PMID: 23376737
   PubMedGoogle Scholar
• Jawerka M, Colak D, Dimou L, Spiller C, Lagger S, Montgomery RL, et al. The specific role of histone deacetylase 2 in adult neurogenesis. Neuron Glia Biol 2010; 6:93 - 107; http://dx.doi.org/10.1017/S1740925X10000049; PMID: 20388229
   PubMed Web of Science ®Google Scholar
• Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics 2012; 4:5; http://dx.doi.org/10.1186/1868-7083-4-5; PMID: 22414492
   PubMed Web of Science ®Google Scholar
• Gräff J, Kim D, Dobbin MM, Tsai LH. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 2011; 91:603 - 49; http://dx.doi.org/10.1152/physrev.00012.2010; PMID: 21527733
   PubMed Web of Science ®Google Scholar
• Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009; 459:55 - 60; http://dx.doi.org/10.1038/nature07925; PMID: 19424149
   PubMed Web of Science ®Google Scholar
• Biermann J, Boyle J, Pielen A, Lagrèze WA. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Mol Vis 2011; 17:395 - 403; PMID: 21311741
   PubMed Web of Science ®Google Scholar
• Montgomery RL, Hsieh J, Barbosa AC, Richardson JA, Olson EN. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci U S A 2009; 106:7876 - 81; http://dx.doi.org/10.1073/pnas.0902750106; PMID: 19380719
   PubMed Web of Science ®Google Scholar
• Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks CM, et al. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 2010; 56:437 - 44; http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.154567; PMID: 20679181
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang H, Yoon SO, Xu X, Hottiger MO, Svaren J, et al. HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat Neurosci 2011; 14:437 - 41; http://dx.doi.org/10.1038/nn.2780; PMID: 21423191
   PubMed Web of Science ®Google Scholar
• Miller RH. Unwrapping HDAC1 and HDAC2 functions in Schwann cell myelination. Nat Neurosci 2011; 14:401 - 3; http://dx.doi.org/10.1038/nn.2788; PMID: 21445062
   PubMed Web of Science ®Google Scholar
• MacDonald JL, Roskams AJ. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development. Dev Dyn 2008; 237:2256 - 67; http://dx.doi.org/10.1002/dvdy.21626; PMID: 18651664
   PubMed Web of Science ®Google Scholar
• Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ. Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 2007; 31:47 - 58; http://dx.doi.org/10.1007/BF02686117; PMID: 17416969
   PubMed Web of Science ®Google Scholar
• Hooker JM, Kim SW, Alexoff D, Xu Y, Shea C, Reid A, et al. Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using Positron Emission Tomography. ACS Chem Neurosci 2010; 1:65 - 73; http://dx.doi.org/10.1021/cn9000268; PMID: 20657706
   PubMed Web of Science ®Google Scholar
• Reid AE, Hooker J, Shumay E, Logan J, Shea C, Kim SW, et al. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain. Nucl Med Biol 2009; 36:247 - 58; http://dx.doi.org/10.1016/j.nucmedbio.2008.12.005; PMID: 19324270
   PubMed Web of Science ®Google Scholar
• Undevia SD, Kindler HL, Janisch L, Olson SC, Schilsky RL, Vogelzang NJ, et al. A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine. Ann Oncol 2004; 15:1705 - 11; http://dx.doi.org/10.1093/annonc/mdh438; PMID: 15520075
   PubMed Web of Science ®Google Scholar
• Pauer LR, Olivares J, Cunningham C, Williams A, Grove W, Kraker A, et al. Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors. Cancer Invest 2004; 22:886 - 96; http://dx.doi.org/10.1081/CNV-200039852; PMID: 15641487
   PubMed Web of Science ®Google Scholar
• Perabo FG, Müller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007; 18:835 - 43; http://dx.doi.org/10.1093/annonc/mdl331; PMID: 17018703
   PubMed Web of Science ®Google Scholar
• Gridelli C, Rossi A, Maione P. The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer. Crit Rev Oncol Hematol 2008; 68:29 - 36; http://dx.doi.org/10.1016/j.critrevonc.2008.03.002; PMID: 18424067
   PubMed Web of Science ®Google Scholar
• Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 2007; 1:19 - 25; http://dx.doi.org/10.1016/j.molonc.2007.01.001; PMID: 19383284
   PubMed Web of Science ®Google Scholar
• Hubeek I, Comijn EM, Van der Wilt CL, Merriman RL, Padron JM, Kaspers GJ, et al. CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo. Oncol Rep 2008; 19:1517 - 23; PMID: 18497959
   PubMed Web of Science ®Google Scholar
• Richards DA, Boehm KA, Waterhouse DM, Wagener DJ, Krishnamurthi SS, Rosemurgy A, et al. Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. Ann Oncol 2006; 17:1096 - 102; http://dx.doi.org/10.1093/annonc/mdl081; PMID: 16641168
   PubMed Web of Science ®Google Scholar
• Chou DH, Holson EB, Wagner FF, Tang AJ, Maglathlin RL, Lewis TA, et al. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis. Chem Biol 2012; 19:669 - 73; http://dx.doi.org/10.1016/j.chembiol.2012.05.010; PMID: 22726680
   PubMed Web of Science ®Google Scholar
• Li-Huei Tsai J-SG, Stephen J. Haggarty, Edward Holson, Florence Wagner, Johannes Graeff, Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders. 2010.
   Google Scholar
• Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A 2010; 107:12617 - 22; http://dx.doi.org/10.1073/pnas.1006774107; PMID: 20616024
   PubMed Web of Science ®Google Scholar
• Cavasin MA, Demos-Davies K, Horn TR, Walker LA, Lemon DD, Birdsey N, et al. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. Circ Res 2012; 110:739 - 48; http://dx.doi.org/10.1161/CIRCRESAHA.111.258426; PMID: 22282194
   PubMed Web of Science ®Google Scholar
• Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, et al. Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 2003; 307:720 - 8; http://dx.doi.org/10.1124/jpet.103.055541; PMID: 12975486
   PubMed Web of Science ®Google Scholar
• Glowinski J, Axelrod J. Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. Pharmacol Rev 1966; 18:775 - 85; PMID: 5904189
   PubMed Web of Science ®Google Scholar
• Allen Brain Atlas. [cited 2012; Available from: http://www.brain-map.org/.
   Google Scholar
• Zhang Y, Holson EB, Wagner FF. inventors. The Broad Institute, Inc., assignee. Fluorescent substrates for determining lysine modifying enzyme activity. United States patent US WO2013067391. 2013 Oct 05.
   Google Scholar
• Holson EW, Weïwer M, Zhang YL. inventors. The Broad Institute, Inc., assignee. Inhibitors of histone deacetylases. United States patent US WO2012149540. 2012 Jan 11.
   Google Scholar
• Li KW, ed. Neuroproteomics (Neuromethods). Dissection of Rodent Brain Regions, ed. S. Spijker. Vol. 57. 2011. 13-26.
   Google Scholar
• Tyllianakis PE, Kakabakos SE, Evangelatos GP, Ithakissios DS. Direct colorimetric determination of solid-supported functional groups and ligands using bicinchoninic acid. Anal Biochem 1994; 219:335 - 40; http://dx.doi.org/10.1006/abio.1994.1273; PMID: 8080090
   PubMed Web of Science ®Google Scholar